Canada Life
RPRX icon

Canada Life’s Royalty Pharma RPRX Stock Holding History

Canada Life’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
+185,316
New +$9.65M 0.02% 523
2025
Q2 		– Sell
-604,565
Closed -$18.9M – 1989
2025
Q1 		$18.9M Buy
+604,565
New +$19.2M 0.03% 423
2024
Q1 		– Sell
-269,966
Closed -$7.54M – 2151
2023
Q4 		$7.54M Buy
+269,966
New +$7.42M 0.02% 616
2021
Q1 		– Sell
-36,765
Closed -$1.84M – 2613
2020
Q4 		$1.84M Buy
+36,765
New +$1.56M ﹤0.01% 1189

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Life's RPRX Position: Q2 2026 in Review

Canada Life opened a new position in Royalty Pharma (RPRX) in Q2 2026: 185,316 shares worth $10.4M. The stake represents 0.02% of the portfolio and ranks #523 among its holdings. This is a return to the name: Canada Life previously reported a position in RPRX as recently as Q1 2025.

Canada Life first reported a position in RPRX in Q4 2020 and has held it in 4 quarters since. The position peaked at $18.9M in Q1 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Canada Life held 185,316 shares of Royalty Pharma worth $10.4M as of Q2 2026.
  • Royalty Pharma was a new Canada Life position in Q2 2026.
  • Royalty Pharma made up 0.02% of Canada Life's portfolio in Q2 2026, its #523 holding.
  • Canada Life first reported a position in Royalty Pharma in Q4 2020 and has held it in 4 quarters since.
  • Canada Life's Royalty Pharma position peaked at $18.9M in Q1 2025.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.